-
-
Name
- AP-214(Modimelanotide)
-
Sequence
- KKKKKKSYSMEHFRWGKPV
-
Description
- Synthetic derivative from HDP α-melanocyte-stimulating hormone
-
-
Target Organism
-
- No MICs found on DRAMP database
-
Reference
-
- AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality.(PMID: 18354376)
-
Medical use
- ①Prevention of acute kidney injury after cardiac surgery; ②Treatment of sepsis.
-
Company
- Action Pharma A/S (Aarhus and Copenhagen, Denmark)
-
Stage of Development
- Phase II (Completed)
-
-
Clinical Trials
- NCT01256372
- NCT00903604
- NCT00628264